Mao Inhibitors: Types, Uses, And Pharmacokinetics Explained

by

Mao inhibitors, also known as monoamine oxidase inhibitors, are a class of medications primarily used to treat depression and other mental health conditions. They work by blocking the enzyme monoamine oxidase, which breaks down neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. This action increases the availability of these chemicals, helping to improve mood and emotional regulation.

Types of Mao Inhibitors

There are two main types of Mao inhibitors based on their selectivity:

  • Non-selective Mao inhibitors: These inhibit both Mao-A and Mao-B enzymes. Examples include phenelzine and tranylcypromine.
  • Selective Mao inhibitors: These target only one type of enzyme. For example, moclobemide selectively inhibits Mao-A, while selegiline selectively inhibits Mao-B.

Uses of Mao Inhibitors

Mao inhibitors are primarily used for:

  • Major depressive disorder, especially when other antidepressants have failed
  • Atypical depression
  • Obsessive-compulsive disorder (OCD)
  • Parkinson’s disease, particularly Mao-B inhibitors like selegiline
  • Chronic migraine prevention

Pharmacokinetics of Mao Inhibitors

The pharmacokinetics of Mao inhibitors involve their absorption, distribution, metabolism, and excretion. They are generally well-absorbed orally, with peak plasma concentrations occurring within 1-3 hours for most drugs. These medications are extensively metabolized in the liver, primarily by cytochrome P450 enzymes.

Half-life varies among different Mao inhibitors. For example, phenelzine has a half-life of approximately 11 hours, while selegiline’s half-life can extend up to 40 hours depending on the formulation. Excretion occurs mainly via the kidneys, with some metabolites eliminated in the urine.

Factors Influencing Pharmacokinetics

  • Age and liver function can affect drug metabolism
  • Drug interactions, especially with other serotonergic or hypertensive agents
  • Dietary intake of tyramine, which can cause hypertensive crises when combined with Mao inhibitors

Understanding the pharmacokinetics of Mao inhibitors is essential for safe prescribing and management, especially considering their interactions and side effect profile.